OptimalHealthSecrets.Com
Reference papers on oils in our diet
Many people have been asking about research on this diet. You should understand that this diet is a compilation of several well researched principles and some other not so well researched principles. When dealing with pain and food the rule we go by is,
when in doubt, leave it out.
That said, there has been quite a lot of research on oils and pain. Several of the major hormones that regulate the inflammatory process come from food, the oils, particularly the essential fatty acids. These foods are not the hormones themselves but rather the precursors to the hormones. The human body cannot make double bonds in fat molecules where they are needed to make the hormones, but plants can, and fish can. So we must eat these fats. If you eat too much of the kind of oil that makes inflammation worse, then you will suffer with more pain than you normally should.
So, here is a list of some 467 papers used as reference for a journal published in 1990. You will see that this information on oils and pain is not new by any means.
On the next page there is a paper by Dr. Meschino on these oils. At the end of his paper there are several more recent references.
These 467 references are from the publication
Reviews in Contemporary Pharmacotherapy
Editors: S. Johnson & F.N. Johnson
Volume 1 Number 1, 1990
Gamma Linolenic Acid
ISSN: 0954-8602
Marinus Press
PO Box 15, Carnforth, LA6 1HW, UK
REFERENCES
1. Mead JF, Fulco AJ. The unsaturated and polyunsaturated fatty acids in health and disease. Springfield: CC Thomas, 1976.
2. Horrobin DF (ed). Omega-6 Essential fatty acids: Pathophysiology and roles in clinical medicine. New York: Alan Liss, 1990.
3. Rivers JPW, Frankel TL. Essential fatty acid deficiency. Br Med Bull 1981; 37: 59-64.
4. Sinclair HM. Essential fatty acids and chronic degenerative diseases. In: Rose J, ed. Nutrition and Killer Diseases. Park Ridge NJ: Noytes, 1982: 69-83.
5. Holman RT. George 0 Burr and the discovery of essential fatty acids. J Nutr 1988; 118: 535-540.
6. Holman RT. Control of polyunsaturated acids in tissue lipids. J Am Coll Nutr 1986; 5: 183-211.
7. Alfin-Slater RB, Aftergood L. Essential fatty acids reinvestigated. Physiol Rev 1968; 48: 758-784.
8. Garcia PT, Holman RT. Competitive inhibitions in the metabolism of polyunsaturated fatty acids studied via the composition of the phospholipids, triglycerides and cholesterol esters of rat tissues. J Am Oil Chem Soc 1965; 42: 1137-1141.
9. Sprecher H. Biochemistry of essential fatty acids. Prog Lipid Res 1982; 20: 13-22.
10. Brenner RR. Nutritional and hormonal factors in- fluencing desaturation of essential fatty acids. Prog Lipid Res 1982; 20: 41-48.
11. Horrobin DF. The regulation of prostaglandin biosynthesis by the manipulation of essential fatty acid metabolism. Rev Pure Appi Pharmacol Sci 1983; 4: 339-342.
12. Maeda M, Doi 0, Akamatsu Y. Metabolic conversion of polyunsaturated fatty acids in mammalian cultured cells. Biochim Biophys Acta 1978; 530: 153-164.
13. Sinclair HM. Essential fatty acids and the skin. Br Med Bull 1958; 14: 258-262.
14. Prottey C. Investigation of functions of essential fatty acids in the skin. Br J Dermatol 1977; 97: 29-38.
15. Nugteren DH, Christ-Hazelhof E, van der Beck A et al. Metabolism of linoleic acid and other essential fatty acids in the epidermis of the rat. Biochem Biophys Acta 1985; 834: 429-436.
16. Haas TA, Bastida E, Nakamura K et al. Binding of 13-HODE and 5-, 12- and 15-HETE to endothelial cells and subsequent platelet, neutrophil and tumor cell adhesion. Biochim Biophys Acta 1988; 961: 153-159.
17. Thomasson HJ. Essential fatty acids. Nature 1954; 173: 452.
18. Hassam AG, Rivers JPW, Crawford MA. Metabolism of gamma-linolenic acid in essential fatty acid-deficient rats. J Nutr 1977; 107: 519-524.
19. Hassam AG. The influence of alpha-linolenic acid (18:3w3) on the metabolism of gamma-linolenic acid (18:3w6) in the rat. Br J Nutr 1977; 38: 137-140.
20. Frankel TL, Rivers JPW. The nutritional and metabolic impact of gamma-linolenic acid on cats deprived of animal lipid. Br J Nutr 1978; 39: 227-231.
21. Gibson RA, Kneebone GM. Fatty acid composition of human colostrum and mature breast milk. Am J Clin Nutr 1981; 34: 252-260.
22. Harzer G, Haug M, Dieterich I, Gentner PR. Changing patterns of human milk lipids in the course of lactation and during the day. Am J Clin Nutr 1983; 37: 612-622.
23. Qureshi AA, Schnoes HK, Din ZZ, Peterson DM. Determination of the structure of cholesterol inhibitor II isolated from high protein barley flour. Fed Proc 1984; 43: 2626.
24. Hudson BJF. Evening primrose (Oenothera spp.) oil and seed. J Am Oil Chem Soc 1984; 61(3): 540-543.
25. Traitler H, Winter H, Richli U, Ingenbleek Y. Characterization of gamma-linolenic acid in Ribes seed. Lioids 1984; 19: 923-928.
26 Whipkey A, Simon JE, Janick J. In vivo and in vitro lipid accumulation in Borago officinalis L. J Am Oil Chem Soc 1988; 65: 979-984.
27. Muderhwa JM, Dhuique-Mayer C, Pina M. Distribution of fatty acids in the triglycerides of gamma-linolenic acid containing oils. Oleagineux 1987; 42: 207-211.
28. Fukuda H, Morikawa H. Enhancement of gamma-linolenic acid production by Mucor ambiguus with nonionic surfactants. Appi Microbiol Biotechnol 1987; 27: 15-20.
29. Hansson L, Dostaiek M. Effect of culture conditions on mycelial growth and production of gamma-linolenic acid by the fungus Mortierella ramanniana. Appi Microbiol Biotechnol 1988; 28: 240-246.
30. Roughan PG. Spirulina: A source of dietary gamma-linolenic acid? J Sci Food Agric 1989; 47: 85-93.
31. Horrobin DF, Manku MS. Clinical biochemistry of
essential fatty acids. In: Horrobin DF, ed. Omega-6
essential fatty acids: Pathophysiology and roles in
clinical medicine. New York: Alan R Liss, 1990:
21-53.
32. Mitsuhashi N, Takano A, Kato J. Inhibition of the
binding of R-5020 and rat uterine progesterone recep-
tors by long chain fatty acids. Endocrinol Jpn 1986:
33: 251-256.
33. Clerc-Hoffman F, Vallette G, Secco-Millet C, Christ-
eff N, Benassayag C, Adrien Nunez E. Inhibition of
the uterine binding of estrogens by unsaturated fatty
acids in the immature rat. C R Acad Sci Paris 1983;
296: 53-58.
34. Goodfriend TL, Ball DL. Fatty acid effects on
angiotensin receptors. J Cardiovasc Pharmacol 1986;
8: 1276-1283.
35. Ho WKK, Cox BM. Reduction of opioid binding in
neuroblastoma X glioma cells grown in medium con-
taining unsaturated fatty acids. Biochim Biophys Acta
1982; 688: 211-217.
36. Simpson LO. Altered blood rheology in the
pathogenesis of diabetic and other neuropathies. Mus-
cle Nerve 1988; 11: 725-744.
37. Abdulla YH, Adams CWM, Morgan RS. Differential
resorption rates of subcutaneous implants of ^H-
cholesterol, various ^H-cholesterol esters and ^H-
cholesterol-l-^C-linolenate. J Atheroscler Res 1969;
9: 81-85.
38. Philbrick D-J, Mahadevappa VG, Ackman RG,
Holub BJ. Ingestion of fish oil or a derived n-3 fatty
acid concentrate containing eicosapentaenoic acid
affects fatty acid compositions of individual phospholi-
pids of rat brain, sciatic nerve and retina. J Nutr 1987;
117: 1663-1670.
39. Neuringer M, Anderson GJ, Connor WE. The essen-
tiality of n-3 fatty acids for the development and
function of the retina and brain. Annu Rev Nutr 1988;
8: 517-541.
40. Davidson BC, Goelst K, Cantrill RC. Limiting the
range of polyenoic fatty acids available from purified
diets affects the growth of domestic cats. In vivo 1989;
3: 183-186.
41. Ziboh VA, Chapkin RS. Biologic significance oi
polyunsaturated fatty acids in the skin. Arch Dermatol
1987; 123: 1686a-1690a.
42. Kramar J, Levine VE. Influence of fats and fatty acids
on the capillaries. J Nutr 1953; 50: 149-160.
43. Williams G, Crawford MA, Pen-in WF. Comparison
of the fatty acid component in structural lipids from
dolphin, zebra and giraffe: possible evolutionary im-
plications. J Zool Lond 1987; 213: 673-684.
44. Huang Y-S, Horrobin DF. Sex differences in n-3 and
n-6 fatty acid metabolism in EFA-depleted rats. Proc
Soc Exp Biol Med 1987; 185: 291-296.
45. Loeb HG, Burr GO. A study of sex difference in the
composition of rats with emphasis on the lipid compo-
nent. J Nutr 1947; 33: 541-551.
46. Greenberg SM, Calbert CE, Savage EE, Deuel H.
The effect of fat level of the diet on general nutrition.
6. The interrelation of linoleate and linolenate in
supplying the essential fatty acid requirement in the
rat. J Nutr 1950; 41: 473-486.
47. Mohrhauer H, Holman RT. The effect of dose level
of EFA upon fatty acid composition of the rat liver. J
Lipid Res 1963; 4: 151-159.
48. Aftergood L, Alfin-Slater RB. Dietary and gonadal
hormone effects on lipid metabolism in the rat. J
Lipid Res 1965; 6: 287-294.
49. Lyman RL, Ostwald R, Bouchard P, Shannon A.
Effect of sex and gonadal hormones on rat plasma
lipids during the development of an essential fatty acid
deficiency. Biochem J 1966; 98: 438-450.
50. Pudelkewicz C, Seufert J, Holman RT. Requirements
of the female rat for linoleic and linolenic acids. J
Nutr 1968; 64: 138-150.
51. Peifer JJ, Holman RT. Essential fatty acids, diabetes
and cholesterol. Arch Biochem Biophys 1955; 57:
520-521.
52. Emken EA. Nutrition and biochemistry of trans and
positional fatty acid isomers in hydrogenated oils. Am
Rev Nutr 1984; 4: 339-376.
53. Enig MG, Munn RJ, Keeney M. Dietary fat and
cancer trends - a critique. Fed Proc 1978; 37: 2215-
2220.
54. Horrobin DF, Huang YS. The role of linoleic acid
and its metabolites in the lowering of plasma
cholesterol and the prevention of cardiovascular dis-
ease. Int J Cardiol 1987; 17: 241-255.
55. Holman RT. Aaes-Jorgensen E. Effects of trans fatty
acid isomers upon essential fatty acid deficiency in
rats. Proc Soc Exp Biol Med 1956; 109: 1759-1765.
56. Hill EG, Johnson SB, Holman RT. Intensification of
essential fatty acid deficiency in the rat by dietary
trans fatty acids. J Nutr 1979; 109: 1759-1765.
57. Holman RT. Perturbation of the metabolism of essen-
tial fatty acids by dietary partially hydrogenated veget-
able oil. Proc Nati Acad Sci USA 1982; 79: 953-957.
58. Ohirogge JB, Emken EA, Gulley RM. Human tissue
lipids: occurence of fatty acid isomers from dietary
hydrogenated oils. J Lipid Res 1981; 22: 955-960.
59. Kummerow FA. Nutrition imbalance and angiotoxins
as dietary risk factors in coronary heart disease. Am
Clin Nutr 1979; 32: 58-83.
60. Kritchevsky D. Trans fatty acids in experimental
atherosclerosis. Fed Proc 1982; 41: 2813-2817.
61. Horrobin DF, Huang Y-S, Cunnane SC, Manku MS.
Essential fatty acids in plasma, red blood cells and
liver phospholipids in common laboratory animals as
compared to humans. Lipids 1984; 19: 806-811.
62. Sinclair AJ. Essential fatty acid requirements of diffe-
rent species. Proc Nutr Soc Aust 1985; 10; 41-48.
63. Kendler BS. Gamma-linolenic acid: physiological
effects and potential medical applications. J Appi Nutr
1987; 39: 79-93.
64. Horrobin DF, Manku MS. Essential fatty acids in
clinical medicine. Nutr Health 1983; 2: 127-134.
65. Horrobin DF. Clinical aspects of essential fatty acids
(EFAs). Farm Tijdschr Beig 1988; 65: 164-167.
66. Horrobin DF. Clinical aspects of the uses of gamma-
linolenic acid. Presented at International Symposium
on New Aspects of Dietary Lipids. Swedish Institute
for Food Research, Goteborg, Sept, 1989.
67. Horrobin DF. Polyunsaturated oils of marine and
plant origin and their uses in clinical medicine. In:
Galli C, ed. Dietary n-3 and n-6 fatty acids: Biological
effects and nutritional essentiality. New York: Plenum
Press, 1988: 297-307.
68. Horrobin DF. Prostaglandins: Physiology and clinical
significance. Edinburgh: Churchill Livingstone, 1978.
69. Kirtland SJ. Prostaglandin Ei: a review. Prostaglan-
dins Leukot Essent Fatty Acids 1988; 32: 165-174.
70. Horrobin DF. Prostaglandin Ei: physiological signifi-
cance and clinical use. Wien Klin Wochenschr 1988;
10: 471-477.
71. Willis AL. Nutritional and pharmacological factors in
eicosanoid biology. Nutr Rev 1981; 39: 289-300.
72. Miller CC, McCreedy CA, Jones AD, Ziboh VA.
Oxidative metabolism of dihomogammalinolenic acid
by guinea pig epidermis: evidence of generation of
anti-inflammatory products. Prostaglandins 1988; 35:
917-938.
73. Miller CC, Ziboh VA. Gamma-linolenic acid-enriched
diet alters cutaneous eicosanoids. Biochem Biophys
Res Commun 1988; 154: 967-974.
74. Ziboh VA. Biochemical basis for the anti-
inflammatory action of gamma-linolenic acid. In: Hor-
robin DF, ed. Omega-6 essential fatty acids:
Pathophysiology and roles in clinical medicine. New
York: Alan Liss, 1990: 187-201.
75. Ayala S, Gaspar G, Brenner RR, Peluffo RO, Kunau
W. Fate of linoleic, arachidonic, and docosa-
7,10,13,16-tetraenoic acids in rat testicles. J Lipid Res
1973; 14: 296-305.
76. Peluffo RO, Ayala S, Brenner RR. Metabolism of
fatty acids in the linoleic acid series in testicles of rats.
Am J Physiol 1970; 218: 669-673.
77. Horrobin DF. Loss of delta-6-desaturase activity as a
key factor in aging. Med Hypotheses 1981; 7: 1211-
1220.
78. Darcet P, Driss F, Mendy F, Delhaye N. Effect of a
diet enriched with gamma-linolenic acid on PUFA
metabolism and platelet aggregation in elderly men.
Ann Nutr 1980; 34: 277-290.
79. Hrelia S, Bordoni A, Celadon M et al. Age-related
changes in linoleate and alpha-linolenate desaturation
by rat liver microsomes. Biochem Biophys Res Com-
mun 1989; 163: 348-355.
80. Bordoni A, Biagi PL, Turchetto E, Hrelia S. Aging
influence on delta-6-desaturase activity and fatty acid
composition of rat liver microsomes. Prostaglandins
Leukot Essent Fattv Acids, in Dress.
81. Hrelia S, Bordoni A, Horrobin DF. Reversal of
age-related changes in linoleic and alpha-linolenic acid
desaturation by administration of Efamol evening
primrose oil. Submitted for publication.
82. Brenner RR, Peluffo RO, Mercuri 0, Restelli MA.
Effect of arachidonic acid in the alloxan diabetic rat.
Am J Physiol 1968; 215: 63-69.
83. De Alaniz MJT, Brenner RR. Effect of insulin upon
the lipids of subcellular fractions of rat liver. Acta
Physiol Lat Am 1969; 19: 1-15.
84. De Alaniz MJT, De Gomez Dumm INT, Brenner
RR. The action of insulin and dibutyryl cyclic AMP
on the biosynthesis of polyunsaturated fatty acids of
the alpha-linolenic acid family in HTC cells. Mol Cell
Biochem 1976; 12: 3-8.
85. Faas FH, Carter WJ. Altered fatty acid desaturation
and microsomal fatty acid composition in streptozoto-
cin diabetic rat. Lipids 1980; 15: 953-961.
86. Faas FH, Carter WJ. Altered microsomal lipid com-
position in the streptozotocin diabetic rat. Lipids 1983;
18: 339-342.
87. Friedman N, Gellhorn A, Benjamin W. Synthesis of
arachidonic acid from linoleic acid in vivo in diabetic
rats. Israel J Med Sci 1966; 2: 677-682.
88. Holman RT, Johnson SB, Gerrard JM et al. Arachi-
donic acid deficiency in streptozotocin-induced di-
abetes. Proc Nat Acad Sci USA 1983; 80: 2375-2379.
89. Huang Y-S, Fujii K, Takahashi R et al. Effect of
diabetes on the metabolism of n-3 and n-6 fatty acids
in rats. IRCS J Med Sci 1985; 13: 1145-1146.
90. Huang Y-S, Takahashi R, Fujii K. Effect of type of
diet on docosahexaenoic acid level in streptozotocin-
induced diabetic rat. J Am Oil Chem Soc 1986; 63:
476.
91. Mercuri 0, Peluffo RO, Brenner RR. Depression of
microsomal desaturation of linoleic to gamma-linolenic
acid in the alloxan diabetic rat. Biochim Biophys Acta
1966; 116: 407-411.
92. Poisson J-P. Comparative in vivo and in vitro study of
the influence of experimental diabetes on rat liver
linoleic acid 6- and 5-desaturation. Enzyme 1985; 34:
1-14.
93. Poisson J-P, Blond J-P. Effect of streptozotocin di-
abetes upon the in vivo conversion of ^C-gamma-
linolenic and dihomogammalinolenic acids into arachi-
donic acid in kidneys and whole rat. Diabete Metab
1985; 11: 289-294.
94. Poisson J-P, Blond J-P, Lemarchal P. Influence of
streptozotocin diabetes on conversion of gamma-
linolenic and dihomogammalinolenic acids to arachi-
donic acid in the rat in vivo. Diabete Metab 1979; 5:
43-46.
95. Poisson J-P, Lemarchal P, Blond J-P et al. Influence
of alloxan diabetes on the conversion of linoleic and
gamma-linolenic acids to arachidonic acid in the rat in
vivo. Diabete Metab 1978; 4: 39-45.
96. Wilder PJ, Coniglio JG. The effects of streptozotocin
diabetes and of dietary protein content on the com-
position and metabolism of testicular lipids. Proc Soc
Exp Biol Med 1984; 177: 399-405.
97. Huang Y-S, Horrobin DF, Manku MS, Mitchell J,
Ryan MA. Tissue phospholipid fatty acid composition
in the diabetic rat. Lipids 1984; 19: 367-370.
98. Horrobin DF. The roles of essential fatty acids in the
development of diabetic neuropathy and other com-
plications of diabetes mellitus. Prostaglandins Leukot
Essent Fatty Acids 1988; 31: 181-197.
99. Mikhailidis DP, Kirtland S, Barradas MA, Dandona
P. Dihomogammalinolenic acid inhibits platelet
aggregation and stimulates platelet prostaglandin Ei
production in healthy subjects but not insulin-
dependent diabetics. Prog Lipid Res 1986; 25: 303-
304.
100. Mikhailidis DP, Kirtland SJ, Barradas MA et al. The
effect of dihomogammalinolenic acid on platelet
aggregation and prostaglandin release, erythrocyte
membrane fatty acids and serum lipids: evidence for
defects in PGE1synthesis and delta-5-desaturase activ-
ity in insulin-dependent diabetics. Diabetes Res 1986;
3: 7-12.
101. El Boustani S, Descomps B, Monnier L et al. In vivo
conversion of dihomogammalinolenic acid into arachi-
donic acid in man. Prog Lipid Res 1986; 25: 67-71.
102. Jones DB, Carter RD, Haitas B, Mann JI. Low
phospholipid arachidonic acid values in diabetic
platelets. Br Med J 1983; 286: 173-175.
103. Miettinen TA, Tilvis RS. Effect of fish oil on serum
lipids and fatty acids of red cells and platelets in
diabetes mellitus. Circulation 1984; 70 Suppi II: 288-
294.
104. Tilvis RS, Miettinen TA. Fatty acid composition of
serum lipids, erythrocytes and platelets in insulin-
dependent women. J Clin Endocrinol Metab 1985; 61:
741-745.
105. Tuna N, Frankhausen S, Goetz FC. Total serum fatty
acids in diabetes: relative and absolute concentrations
of individual fatty acids. Am J Med Sci 1968; 255:
120-130.
106. Ling SM, Liu SH. Studies on plasma lipids. I. Fatty
acids of blood plasma in diabetes and nephrosis.
Chinese J Physiol 1928; 2:157-162.
107. Berend N. Uber die Rolle der stark ungesttigten
fettsauren im organismus. Biochem Zeitschr 1932;
246: 117-123.
108. Tilvis RS, Helve E, Miettinen TA. Improvement ol
diabetic control by continuous subcutaneous insulin
infusion therapy changes fatty acid composition ol
serum lipids and erythrocytes in type I (insulin-
dependent) diabetes. Diabetologia 1986; 29: 690-694.
109. Kingsbury KJ, Brett C, Stovold R, Chapman A,
Anderson J, Morgan DM. Abnormal fatty acid com-
position and human atherosclerosis. Postgrad Med
1974; 50: 425-440.
110. Oliver MF. Diet and coronary heart disease. Hum
Nutr Clin Nutr 1982; 36C: 413-427.
111. Simpson GCR, Barker K, Carter RD, Cassels E,
Mann JI. Low dietary intake of linoleic acid predis-
poses to myocardial infarction. Br Med J 1982; 285:
683-684.
112. Riemersma RA, Wood DA, Butler S et al. Linoleic
content in adipose tissue and coronary heart disease.
Br Med J 1986; 292: 1423-1427.
113. Wood DA, Butler S, Riemersma RA et al. Adipose
tissue and platelet fatty acids and coronary heart
disease in Scottish men. Lancet 1984; 2: 117-121.
114. Oliver MF. Cigarette smoking, polyunsaturated fats,
linoleic acid, and coronary heart disease. Lancet 1989;
i: 1241-1243.
115. Oliver MF, Riemersma RA, Thomson M, Fulton M,
Abraham RA, Wood DA. Linoleic acid and coronary
heart disease. Br J Hosp Med 1989; 42: 298-302.
116. Oliver MF, Riemersma RA, Thomson M, Fulton M,
Abraham RA, Wood DA. Linoleic acid and coronary
heart disease. In: Horrobin DF, ed. Omega-6 essential
fatty acids: Pathophysiology and roles in clinical medi-
cine. New York: Alan Liss, 1990: 121-126.
117. Salonen JT, Salonen R, Pentilla I. Serum fatty acids,
apolipoproteins, selenium and vitamin antioxidants
and the risk of death from coronary artery disease.
Am J Cardiol 1985; 56: 226-231.
118. Huang Y-S, Manku MS, Horrobin DF. The effects of
dietary cholesterol on blood and liver polyunsaturated
fatty acids and on plasma cholesterol in rats fed
various types of fatty acid diet. Lipids 1984; 19:
664-672.
119. Horrobin DF. A new concept of cardiovascular dis-
ease: the importance of interactions between
cholesterol, essential fatty acids, prostaglandin E1and
TXA2. Med Hypotheses 1980; 6: 785-800.
120. Nervi AM, Peluffo RO, Brenner RR. Effect of etha-
nol administration on fatty acid desaturation. Lipids
1980; 15: 263-268.
121. Horrobin DF. A biochemical basis for alcoholism and
n for alcohol-induced damage, including the fetal alco-
hol syndrome and cirrhosis: interference with essential
fatty acid and prostaglandin metabolism. Med
Hypotheses 1980; 6: 785-800.
122. Horrobin DF. Essential fatty acids, prostaglandins and
alcoholism: an overview. Alcoholism: Clin Exp Res
1987; 11: 2-9.
123. Horrobin DF. Essential fatty acids, psychiatric dis-
orders and neuropathies. In: Horrobin DF, ed.
Omega-6 essential fatty acids: Pathophysiology and
roles in clinical medicine. New York: Alan Liss, 1990:
305-319.
124. Ailing C, Aspenstrom G, Dencker SJ, Svennerholm
L. Essential fatty acids in chronic alcoholism. Acta
Med Scand 1970; Suppi 631: 1-38.
125. Anggard E, Ailing C, Becker W, Jones AW. Chronic
ethanol exposure enhances essential fatty acid de-
ficiency in rats. Adv Prostaglandin Thromboxane Res
1983; 12: 217-222.
126. Glen AIM, Glen EMT, MacDonell LEF, Skinner FE.
Essential fatty acids and alcoholism. In: Horrobin DF,
ed. Omega-6 essential fatty acids: Pathophysiology
and roles in clinical medicine. New York: Alan Liss,
1990: 321-332.
127. Glen AIM, Skinner F, Glen EMT, MacDonell L. The
role of essential fatty acids in alcohol dependence and
tissue damage. Alcoholism Clin Exp Res 1987; 11:
37-41.
128. Stoesser AV. Effect of acute infection on iodine
number of serum fatty acids. Proc Soc Exp Biol Med
1935; 32: 1326-1327.
129. Begin ME, Ells G, Manku MS, Horrobin DF. Fatty
acid composition of plasma from AIDS patients and
normal individuals. Arch AIDS Res 1988; 3: 159-166.
130. Williams LL, Doody DM, Horrocks LA. Serum fatty
acid proportions are altered during the year following
acute Epstein-Barr virus infection. Lipids 1988; 23:
981-988.
131. Behan PO, Behan WMH, Horrobin DF. A placebo-
controlled trial of n-3 and n-6 essential fatty acids in
the treatment of post-viral fatigue syndrome. Submit-
ted for publication.
132. Dunbar LM, Bayley JM. Enzyme deletions and essen-
tial fatty acid metabolism in cultured cells. J Biol
Chem 1975; 250: 1152-1154.
133. Bayley JM. Lipid metabolism in cultured cells. In:
Snyder F, ed. Lipid metabolism in mammals. New
York: Plenum Press, 1977: 352-364.
134. Horrobin DF. Essential fatty acids, lipid peroxidation
and cancer. In: Horrobin DF, ed. Omega-6 essential
fatty acids: Pathophysiology and roles in clinical medi-
cine. New York: Alan Liss, 1990: 351-378.
135. Horrobin DF. The reversibility of cancer: the rele-
vance of cyclic AMP, calcium, essential fatty acids and
prostaglandin Ei. Med Hypotheses 1980; 6: 469-486.
136. Chiappe LE, De Tomas ME, Mercuri 0. In vitro
activity of delta-6- and delta-9-desaturases in hepato-
mas of different growth rates. Lipids 1974; 9: 489-490.
137. Howards BV, Howard WJ. Lipid metabolism in cul-
tured cells. Adv Lipid Res 1974; 12: 52-96.
138. De Alaniz MJT, Ponz G, Brenner RR. Biosynthesis
of desaturated fatty acids in cultured minimal devia-
tion hepatoma 7288C cells. Acta Physiol Lat Am
1975; 25: 1-11.
139. Reitz RC, Thompson HA, Morris HP. Mitochondrial
and microsomal phospholipids of Morris hepatoma
7777. Cancer Res 1977; 37: 561-567.
140. Morton RE, Hartz JW, Reitz RC. The acyl-CoA
desaturases of microsomes from rat liver and the
Morris 7777 hepatoma. Biochim Biophys Acta 1979;
573: 321-331.
141. De Antueno RJ, Niedfeld G, De Tomas ME. Micro-
somal fatty acid desaturation and elongation in a
human lung carcinoma growth in nude mice. Biochem
Int 1988; 16: 413-420.
142. Begin ME. Effects of polyunsaturated fatty acids and
of their oxidation products on cell survival. Chem
Phys Lipids 1987; 45: 269-313.
143. Bettger WJ, Reeves PG, Moscatelli EA, O'Dell BL.
Interaction of zinc and essential fatty acids in the rat.
J Nutr 1979; 109: 480-490.
144. Huang Y-S, Cunnane SC, Horrobin DF, Davignon J.
Most biological effects of zinc deficiency corrected by
gamma-linolenic acid but not by linoleic acid. Ather-
osclerosis 1982; 41: 193-207.
145. Cunnane SC, Horrobin DF. Parenteral linoleic and
gamma-linolenic acids ameliorate the gross effects of
zinc deficiency. Proc Soc Exp Biol Med 1980; 164:
583-588.
146. Ayala S, Brenner RR. Efecto de la carencia de zinc
sobre la biosintesis in vivo de los acidos grasos de la
serie linoleica en la rata. Acta Physiol Pharmacol Lat
Am. 1987; 37: 321-330.
147. Dib A, Carreau J-P. Effects of gamma-linolenic acid
supplementation on lipogenesis regulation in pregnant
zinc-deficient rat and fetus. Int J Biochem 1986; 18:
1053-1056.
148. Dib A, Carreau J-P. Effects of gamma-linolenic acid
supplementation on pregnant rats fed a zinc-deficient
diet. Ann Nutr Metab 1987; 31: 312-319.
149. Cunnane SC, Manku MS, Horrobin DF. Accumula-
tion of linoleic and gamma-linolenic acids in tissue
lipids of pyridoxine-deficient rats. J Nutr 1984; 114:
1754-1761.
150. Sherman H. Pyridoxine and fat metabolism. Vitam
Horm 1950; 8: 55-68.
151. Witten PW, Holman RT. Polyethenoid fatty acid
metabolism. VI. Effects of pyridoxine on essential
fatty acid conversions. Arch Biochem Biophys 1952;
41: 266-273.
152. Williams MA, Hincenbergs J. Methyl arachidonate
supplementation of vitamin B6-deficient rats. Arch
Biochem Biophys 1959; 83: 564-565.
153. Swell L, Law MD, Schools PE, Treadwell CR. Tissue
lipid composition in pyridoxine-deficient rats. J Nutr
1961; 74: 148-156.
154. Kirschmann JC, Coniglio JG. The role of pyridoxine
in the metabolism of polyunsaturated fatty acids in
rats. J Biol Chem 1961; 236: 2200-2204.
155. Sato Y. A possible role of pyridoxine in lipid metabol-
ism. Nagoya J Med Sci 1970; 33: 105-130.
156. Dussault PE, Lepage M. Effects of pyridoxine de-
ficiency on the composition of plasma and liver fatty
acids in rats fed low and high fat diets. J Nutr 1975;
105: 1371-1376.
157. Mahfouz MM, Kummerow FA. Effect of magnesium
deficiency on delta 6 desaturase activity and fatty acid
composition of rat liver microsomes. Lipids 1989;
24:727-732.
158. Cunnane SC, Soma M, McAdoo KR, Horrobin DF.
Magnesium deficiency in the rat increases tissue levels
of docosahexaenoic acid. J Nutr 1985; 115: 1498-1503.
159. Soma M, Cunnane SC, Horrobin DF. Effects of low
magnesium diet on the vascular prostaglandin and
fatty acid metabolism in rats. Prostaglandins 1988; 36:
431-441.
160. Hansen AE. Role of unsaturated dietary fat in infant
nutrition. Am J Public Health 1957; 47: 1367-70.
161. Hansen AE, Haggard ME, Boelsche AN et al. Essen-
tial fatty acids in human nutrition. III. Clinical man-
ifestations of linoleic acid deficiency. J Nutr 1958; 66:
565-576.
162. Hansen AE. Serum lipid changes and therapeutic
effects of various oils in infantile eczema. Proc Soc
Exp Biol Med 1933; 31: 160-161.
163. Hansen AE. Serum lipids in eczema and other patho-
logical conditions. Am J Dis Child 1937; 53: 933-946.
164. Brown WR, Hansen AE. Arachidonic acid and
linoleic acid of serum in normal and eczematous
human subjects. Proc Soc Exp Biol Med 1937; 30:
113-116.
165. Manku MS, Horrobin DF, Morse N et al. Reduced
levels of prostaglandin precursors in the blood of
atopic patients: defective delta-6-desaturase function
as a biochemical basis for atopy. Prostaglandins
Leukot Med 1982; 9: 615-628.
166. Manku MS, Horrobin DF, Morse NL et al. Essential
fatty acids in the plasma phospholipids of patients
with atopic eczema. Br J Dermatol 1984; 110: 643-
648.
167. Strannegard I-L, Svennerholm L, Strannegard 0.
Essential fatty acids in serum lecithin of children with
atopic dermatitis and in umbilical cord serum of
infants with high or low IgE levels. Int Arch Allergy
Appi Immunol 1987; 82: 422-423.
168. Wright S, Bolton C. Breast milk fatty acids in mothers
of children with atopic eczema. Br J Nutr 1989; 62:
693-697.
169. Wright S, Sanders TAB. Adipose tissue fatty acid
composition in patients with atopic eczema. Submitted
for publication.
170. Schalin-Karrila M, Mattila L, Jansen CT et al. Even-
ing primrose oil in the treatment of atopic eczema:
effect on clinical status, plasma phospholipid fatty
acids and circulating blood prostaglandins. Br J Der-
matol 1987; 117: 11-19.
171. Nikkari T, Salo M, Maatela J, Aromaa A. Serum
fatty acids in Finnish men. Atherosclerosis 1983; 49:
139-148.
172. Melnik BC, Plewig G. Is the origin of atopy linked to
deficient conversion of w-6 fatty acids to prostaglandin
Ei? J Am Acad Dermatol 1989; 21: 557-563.
173. Atton-Chamla A, Faure G, Goudard J-R. Premen-
strual syndrome and atopy. Pharmatherapeutica 1980;
2: 481-486.
174. Brush MG, Watson SJ, Horrobin DF, Manku MS.
Abnormal essential fatty acid levels in plasma of
women with premenstrual syndrome. Am J Obstet
Gynaecol 1984; 10: 363-366.
175. Horrobin DF, Manku MS. Premenstrual syndrome
and premenstrual breast pain (cyclical mastalgia): dis-
orders of essential fatty acid (EFA) metabolism. Pros-
taglandins Leukot Essent Fatty Acids 1989; 37: 255-
261.
176. Horrobin DF, Begin ME. Essential fatty acids: meta-
bolism and clinical use. In: Weber HU, ed. Handbook
of free radicals and anti-oxidants in biomedicine. Boca
Raton: CRC Press, in press.
177. Halliwell B, Gutteridge JMC. Free radicals in biology
and medicine. Oxford: Oxford University Press, 1985.
178. Dormandy TL. An approach to free radicals. Lancet
1983; ii: 1010-1014.
179. Horrobin DF. Post-viral fatigue syndrome, viral infec-
tions in atopic eczema and essential fatty acids. Med
Hypotheses, in press.
180. Pottathil R, Chandrabose KA, Cuatrecasas P, Lang
DJ. Establishment of the interferon-mediated antiviral
state: role of fatty acid cyclo-oxygenase. Proc Nati
Acad Sci USA 1980; 7: 5437-5440.
181. Chandrabose KA, Cuatrecasas P, Pottathil R, Lang
DJ. Interferon-resistant cell line lacks cyclo-oxygenase
activity. Science 1981; 212: 329-331.
182. Strannegard 0, Strannegard I-L, Rystedt I. Viral
infections in atopic dermatitis. Acta Derm Venereol
(Stockh) 1985; Suppi 114: 121-124.
183. Hanifin J, Lobitz WC. Newer concepts of atopic
dermatitis. Arch Dermatol 1977; 113: 663-670.
184. Currie JM, Wright RC, Miller OG. The frequency of
warts in atopic patients. Cutis 1971; 8: 243-244.
185. Solomon LM, Telner P. Eruptive molluscum con-
tagiosum in atopic dermatitis. Can Med Ass J 1966;
95: 978-979.
186. Strannegard I-L, Strannegard 0. Epstein-Barr virus
antibodies in children with atopic disease. Int Archs
Allergy Appi Immunol 1981; 64: 314-319.
187. Rystedt I, Strannegard I-L, Strannegard 0. Increased
serum levels of antibodies to Epstein-Barr virus in
adults with history of atopic dermatitis. Int Archs
Allergy Appi Immunol 1984; 75: 179-183.
188. Rystedt I, Strannegard I-L, Strannegard 0. Recurrent
viral infections in patients with past or present atopic
dermatitis. Br J Dermatol 1986; 114: 575-582.
189. Manku MS, Morse-Fisher N, Horrobin DF. Changes
in human plasma essential fatty acid levels as a result
of administration of linoleic acid and gamma-hnolenic
acid. Eur J Clin Nutr 1988; 42: 55-60.
190. Hassam AG, Sinclair AJ, Crawford MA. The incor-
poration of orally fed radioactive gamma-linolenic acid
and linoleic acid into the liver and brain lipids of
suckling rats. Lipids 1975; 10: 417-420.
191. Huang Y-S, Watanabe Y, Horrobin DF, Simmons V.
Fatty acid changes in liver choline and ethanolamine
glycerophospholipids in aspirin treated rats fed linole-
ate, gamma-linolenate and fish oil. Clin Physiol
Biochem 1989; 7: 79-86.
192. Huang Y-S, Horrobin DF, Manku MS, Mitchell J.
Effect of dietary alpha and gamma linolenic acid on
tissue fatty acids in guinea pigs. Proc Soc Exp Biol
Med 1985; 178: 46-49.
193. Huang Y-S, Horrobin DF. Effect of dietary cholester-
ol and polyunsaturated fats on plasma and liver lipids
in guinea pigs. Ann Nutr Metab 1987; 31: 18-28.
194. Huang Y-S, Horrobin DF. Plasma triacylglycerol fatty
acids in diabetic rats fed gamma-linolenic and marine
n-3 fatty acids. Med Sci Res 1987; 15: 1207-1209.
195. de Bravo MMG, de Tomas ME, Mercuri 0. Metabol-
ism of gammalinolenic acid by human blood platelet
microsomes. Biochem Int 1985; 10: 889-896.
196. Vericel E, Lagarde M, Mendy F, Coupron Ph, Decha-
vanne M. Comparative effects of linoleic acid and
gamma-linolenic acid intake on plasma lipids and
platelet phospholipids in elderly people. Nutr Res
1987; 7: 569-580.
197. Takayasu K, Tada T, Okada F, Yoshikawa I. Human
plasma fatty acid composition: the features of hyperli-
poproteinemia and the influence of gamma-linolenate
and clofibrate. Jpn Circ J 1974; 35: 1059-1069.
198. Ide T, Sugano M, Ishida T, Niwa M, Arima M,
Morita A. Effects of gamma-linolenic acid on fatty
acid profiles and eicosanoid production of the hams-
ter. Nutr Res 1987; 7: 1085-1092.
199. Sugano M, Ishida T, Yoshida K, Tanaka K, Niwa M,
Arima M, Morita A. Effects of mold oil containing
gamma-linolenic acid on the blood cholesterol and
eicosanoid levels in rats. Agric Biol Chem 1986; 50:
2483-2491.
200. Choi Y-S, Sugano M. Effects of dietary alpha and
gamma linolenic acid on lipid metabolism in young
and adult rats. Ann Nutr Metab 1988; 32: 169-176.
201. Ishikawa T, Fujiyama Y, Igarashi 0 et al. Effects of
gammalinolenic acid on plasma lipoproteins and apoli-
poproteins. Atherosclerosis 1989; 75: 95-104.
202. Renaud S, McGregor L, Morazain R. Comparative
beneficial effects on platelet functions and atheroscler-
osis of dietary linoleic and gamma-linolenic acids in
the rabbit. Atherosclerosis 1982; 45: 43-51.
203. Hoffmann P, Block H-U, Beitz J et al. Comparative
study of the blood pressure effects of four different
vegetable fats on young, spontaneously hypertensive
rats. Lipids 1986; 21: 733-737.
204. Stone KJ, Willis AL, Hart M et al. The metabolism o\
dihomogamma-linolenic acid in man. Lipids 1979; 14:
174-180.
205. Anon. Effects of feeding dihomogamma-linolenic acid
in man. Nutrition Rev 1979; 37: 286-288.
206. Blond J-P, Lemarchal P, Spielman D. Desaturation of
linoleic and dihomogamma-linolenic acids by human
liver in vitro. C R Acad Sci 1981; 292: 911-914.
207. Horrobin DF, Manku MS, Huang Y-S. Effects of
essential fatty acids on prostaglandin biosynthesis.
Biomed Biochim Acta 1984; 43: 114-120.
208. Horrobin DF. The regulation of prostaglandin
biosynthesis: negative feedback mechanism and the
selective control of 1 and 2 series prostaglandins:
relevance to inflammation and immunity. Med
Hypotheses 1980; 6: 687-709.
209. Horrobin DF. Essential fatty acid metabolism in dis-
eases of connective tissue with special reference to
scleroderma and to Sjogren's syndrome. Med Hypoth-
eses 1984; 14: 233-247.
210. Belch JJF, Shaw B, O'Dowd A et al. Evening prim-
rose oil (Efamol) in the treatment of Raynaud's
phenomenon: a double blind study. Thromb Haemost
1985; 54: 490-494.
211. Puolakka J, Makarainen L, Viinikka L, Ylikorkala 0.
Biochemical and clinical effects of treating the pre-
menstrual syndrome with prostaglandin synthesis pre-
cursors. J Reprod Med 1985; 30: 149-153.
212. Sugano M, Ishida T, Ide T. Effects of various polyun-
saturated fatty acids on blood cholesterol and eicosa-
noids in rats. Agric Biol Chem 1986; 50: 2335-2340.
213. Dodge JA. Essential fatty acids in cystic fibrosis. In:
Horrobin DF, ed. Omega-6 Essential Fatty Acids:
Pathophysiology and roles in clinical medicine. New
York: Alan Liss, 1990: 427-435.
214. Zurier RB, Baker DG.DeMarco D et al. Anti-
inflammatory effects of gamma-linolenic acid: Studies
in animals and in cultured cells. In: Horrobin DF, ed.
Omega-6 Essential Fatty Acids: Pathophysiology and
roles in clinical medicine. New York: Alan Liss, 1990:
203-221.
215. Tate G, Mandell B, Kerolus G et al. Suppression of
experimental acute and chronic inflammation by diets
enriched in gamma-linolenic acid. Arthritis Rheum
1987; 30: 566.
216. Bj0rneboe A, Smith AK, Bj0rneboe GAA et al.
Effect of dietary supplementation with n-3 fatty acids
on clinical manifestations of psoriasis. Br J Dermatol
1988; 118: 77-83.
217. Jensen CD, Spiller GA, Wookey VJ et al. Plasma
lipids on three levels of fish oil intake in healthy
human subjects. Nutr Rep Int 1988; 38: 165-172.
218. Nassar BA, Huang YS, Horrobin DF. Response of
tissue phospholipid fatty acid composition to dietary
(n-6) and replacement with marine (n-3) and saturated
fatty acids in the rat. Nutr Res 1986; 6: 1397-1409.
219. Nassar BA, Huang YS, Manku MS et al. The influ-
ence of dietary manipulation with n-3 and n-6 fatty
acids on liver and plasma phospholipid fatty acids in
rats. Lipids 1986; 21: 652-656.
220. Nassar BA, Manku MS, Huang YS et al. The influ-
ence of dietary marine oil (Polepa) and evening prim-
rose oil (Efamol) on prostaglandin production by the
rat mesenteric vasculature. Prostaglandins Leukot
Med 1987; 26: 253-263.
121. Cleland LG, Gibson RA, Neumann M, French JK.
The effect of dietary fish oil supplement upon the
content of dihomogammalinolenic acid in human plas-
ma phospholipids. Prostaglandins Leukot Essent Fatty
Acids, in press.
122. Horrobin DF. Interactions between n-3 and n-6 essen-
tial fatty acids. Presented at International Symposium
on New Aspects of Dietary Lipids. Swedish Institute
for Food Research, Goteborg, Sept 1989.
123. Horrobin DF. Cardiovascular and inflammatory dis-
eases: interactions between n-3 and n-6 essential fatty
acids. N-3 News, in press.
Z24. Glauber H, Wallace P, Griver K et al. Adverse
metabolic effect of omega-3 fatty acids in non-insulin-
dependent diabetes mellitus. Ann Intern Med 1988;
108: 663-668.
225. Rustemeijer C, Bilo HJG, Beukhof JR et al. The
effect of fish oil concentrate on serum lipids and
lipoproteins in patients on maintenance haemodialysis.
Curr Ther Res 1988; 43: 559-567.
Z26. Kasim SE, Stern B, Khilnani S et al. Effects of
omega-3 fish oil on lipid metabolism, glycemic control
and blood pressure in type II diabetic patients.
J ClinEndocrinol Metab 1988; 67: 1-5.
227. Vandongen R, Mori TA, Codde JP et al. Hyper-
cholesterolaemic effect of fish oil in insulin-dependent
diabetic patients. Med J Aust 1988; 148: 141-143.
228. Demke DM, Peters GR, Linet 01 et al. Effects of a
fish oil concentrate in patients with hypercholesterole-
mia. Atherosclerosis 1988; 70: 73-80.
229. Thiery J, Seidel D. Fish oil feeding results in an
enhancement of cholesterol-induced atherosclerosis in
rabbits. Atherosclerosis 1987; 63: 53-56.
230. Dyerberg J, Bang HO, Hjorne N. Fatty acid composi-
tion of the plasma lipids in Greenland Eskimos. Am J
Clin Nutr 1975; 28: 958-966.
231. Horrobin DF. Low prevalence of coronary heart dis-
ease, psoriasis, asthma and rheumatoid arthritis in
Eskimos: are they caused by high dietary intake of
eicosapentaenoic acid, a genetic variation of essential
fatty acid metabolism or a combination of both. Med
Hypotheses 1987; 22: 421-428.
232. Kromann N, Green A. Epidemiological studies in the
Upernavik District, Greenland. Acta Med Scand 1980;
208: 401-406.
233. Sinclair HM. The human nutritional advantages of
plant foods over animal foods. Qual Plant Fds Hum
Nutr 1979; 29: 7-18.
234. Gibson RA, Sinclair AJ. Are Eskimos obligate carni-
vores? Lancet 1980; i: 1100.
235. Vaddadi KS, Courtney P, Gilleard CJ, Manku MS,
Horrobin DF. A double-blind trial of essential fatty
acid supplementation in patients with tardive dys-
kinesia. Psychiatry Res 1989; 27: 313-323.
236. Corrigan F, Horrobin DF. Essential fatty acid supple-
mentation in psychiatric patients. Submitted for pub-
lication.
237. Grattan CEH, Horrobin DF. Partial reversal of essen-
tial fattv acid abnormalities in chronic urticaria and
clinical improvement after evening primrose oil ther-
apy. Submitted for publication.
238. Davidson B, Kurstjens NP, Patton J, Cantrill RC.
Essential fatty acids modulate apomorphine activity at
dopamine receptors in cat caudate slices. Eur J Phar-
macol 1988; 149: 317-322.
239. Davidson BC, Giangregorio A, Girao LAF. Essential
fatty acids in cheetahs and in domestic cats. In:
Horrobin DF, ed. Omega-6 Essential Fatty Acids:
Pathophysiology and roles in clinical medicine. New
York: Alan Liss, 1990: 99-112.
240. Ackman RG. Some possible effects on lipid bioche-
mistry of differences in the distribution on glycerol of
long-chain n-3 fatty acids in the fats of marine fish and
marine mammals. Atherosclerosis 1988; 70: 171-173.
241. Nelson GJ, Ackman RG. Absorption and transport of
fat in mammals with emphasis on n-3 polyunsaturated
fatty acids. Lipids 1988; 23: 1005-1014.
242. Myher JJ, Marai L, Kuksis A. Acylglycerol structure
of peanut oils of different atherogenic potential.
Lipids 1977; 12: 775-785.
243. Elson CE, Dugan LR, Bratzler LJ, Pearson AM.
Effect of isoessential fatty acid lipids from animal and
plant sources on cholesterol levels in mature male
rats. Lipids 1966; 1: 322-324.
244. El Boustani S, Colette C, Monnier L, Descomps B,
Crastes de Paulet A, Mendy F. Enteral absorption in
man of eicosapentaenoic acid in different chemical
forms. Lipids 1987; 22: 711-714.
245. Christophe A, Verdonk G, Robberecht E, Mahatha-
nakhun R. Effect of supplementing medium chain
triglycerides with linoleic acid-rich monoglycerides on
severely disturbed serum lipid fatty acid patterns in
patients with cystic fibrosis. Ann Nutr Metab 1985;
29: 239-245.
246. Jenkins DK, Mitchell JC, Manku MS, Horrobin DF.
Effects of different sources of gamma-linolenic acid on
the formation of essential fatty acid and prostanoid
metabolites. Med Sci Res 1988; 16: 525-526.
247. Yamamoto I, Sugano M, Wada M. Hypocholester-
olaemic effect of animal and plant fats in rats. Ather-
osclerosis 1971; 13: 171-184.
248. Ratnayake WMN, Matthews DG, Ackman RG.
Triacylglycerols of evening primrose (Oenothera bien-
nis) seed oil. J Am Oil Chem Soc 1989; 66: 966-969.
249. Lawson LD, Hughes BG. Human absorption of fish
oil fatty acids as triacylglycerols, free acids, or ethyl
esters. Biochem Biophys Res Commun 1988; 152 | 
